Genmab — Januar 2018
-
strange, it works for me, can you try copy paste http://worldadc-usa.com/wp-content/uploads/sites/99/2017/09/Heather-Donaghy followed by .pdf
-
-
Multiple Myeloma Patients Remain On Treatment Far Less than in Clinical Trials, Study Finds https://myelomaresearchnews.com/2018/01/12/multiple-myeloma-patients-remain-on-treatment-less-than-clinical-trials-study-finds/?utm_source=Myeloma+List&utm_campaign=2a97d50a48-RSS_WEEKLY_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_14fcd0022a-2a97d50a48-72491777
-
-
Det er godt nok nogen sløv volume der har været de sidste dage. Man kunne jo håbe på at AQR er færdige med at holde udsalg.
-
Selvom man godt kunne fristes til at tro, at de nemt kunne have kørt kursen længere ned under de her lave volumer.
-
Det er plausibelt. Det er i hvert fald ikke gennem Genmab aktien man får sin daglige spænding i disse dage.
-
You're absolutly right E L. It will be the right way - Japan will surprise with the sales.
-
or at least that's what im hoping
-
It's the best way. Short term I'm hoping - long term I know Genmab will be worth my investment.
-
Genmab-kandidat kan forbedre behandling af modermærkekræft
Et præklinisk studie foretaget af kræftforskere i Holland peger på, at en lægemiddelkandidat fra det danske biotekselskab Genmab kan være nøglen til at forbedre behandlingen af en særlig type modermærkekræft.
(medwatch.dk)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind